baber/WOPTO huggingface dataset:
Patent NZ-513116-A (NZ)
Title: Polarized light scattering spectroscopy of tissue
Inventor: FELD MICHAEL S
IPC: A61B5/00
Filed: 2000-01-25
Abstract: A method of detecting dysplasia comprising: a) directing polarized light onto tissue, which includes a first epithelial layer having a region of interest and an underlying tissue layer; b) detecting polarized backscattered light returning from the region of interest. The backscattered light having a component that is periodic as a function of wavelength; c) determining whether the tissue in the region of interest is normal or includes epithelial dysplasia with the detected periodic component of the backscattered light. A fibre optic probe is used as the instrument for conducting the above method.
Patent NZ-515531-A (NZ)
Title: Substituted 3-pyridyl-4-arylpyrroles, and related therapeutic and prophylactic methods
Inventor: BULLINGTON JAMES
IPC: A61K31/4439
Filed: 2000-04-28
Abstract: Substituted 3-pyridyl-4-arylpyrroles of formula (I) and pharmaceutical compositions comprising same, useful for treating disorders ameliorated by reducing TNF-á production and/or p38 activity in appropriate cells.
Patent NZ-521535-A (NZ)
Title: Treatment of pain by peripheral administration of a medicament comprising the botulinum toxin
Inventor: AOKI KEI ROGER
IPC: A61K45/00
Filed: 2001-04-11
Abstract: A botulinum toxin comprising a neuronal binding moiety which is substantially native to the botulinum toxin is used in the manufacture of a medicament for peripheral administration for treating pain not associated with either a muscle spasm or a headache.
Patent NZ-524813-A (NZ)
Title: Optically active 2,5-bisaryl-delta1-pyrrolines and their use as pest control agents
Inventor: PLANT ANDREW
IPC: C07F7/18
Filed: 2001-09-10
Abstract: Optically active "1 (delta)-pyrrolines of the formula (I) where: - * represents a chiral carbon atom having the (R)-configuration, - m represents 0, 1, 2, 3 or 4, - R1 represents halogen or methyl, - R2 represents hydrogen or halogen, - R3 represents hydrogen, halogen, hydroxyl, alkyl, alkenyl, alkinyl, halogenoalkyl, halogenoalkenyl, alkoxy, -S(O)oR6, -OSO2R6, bisalkoxyborane, -B(OH)2 or represents phenyl which is optionally mono- or polysubstituted by radicals from the list W1, - R4represents halogen, alkyl, alkoxy, halogenoalkyl, halogenoalkoxy or -S(O)oR6, - W1 represents cyano, halogen, hydroxyl, alkyl, halogenoalkyl, alkenyl, halogenoalkenyl, alkoxy, halogenoalkoxy, alkenyloxy, halogenoalkenyloxy, alkoxycarbonyl, trialkylsilyl, trialkylsilyloxy, -CONH2, -NR7R8, -S(O)oR6 or -SO2NR7R8, - o represents 0, 1 or 2, - R6 represents hydrogen, alkyl or halogenoalkyl, - R7 and R8 independently of one another each represent hydrogen, alkyl, halogenoalkyl or together represent alkylene or alkoxyalkylene. Compounds of formula (I) may be used as pesticides.
Patent NZ-531975-A (NZ)
Title: Concealed object recognition
Inventor: GRINDSTAFF GENE ARTHUR
IPC: G06V10/20
Filed: 2002-09-06
Abstract: A method for viewing a first object having a contrasting color to a second object, wherein the second object obstructs visibility of the first object, wherein visible light passes through the second object, is disclosed. The method comprises: (a) receiving digital image data, including pixel parameter values, given in gray gradation or light intensity, representative of the first object obstructed by the second object into a computer system; wherein the digital image data contains at least first object data and second object data produced by visible light reflecting off of the first and second objects, and each datum has an associated value; (b) substantially filtering out the pixel parameter values, given in gray gradations or light intensity, of the second object data; and (c) increasing pixel parameter values, given in gray gradation or light intensity, of the first object data until visibly displayable.
Patent NZ-532373-A (NZ)
Title: Pyrimidine compound and medicinal composition thereof
Inventor: HARADA HITOSHI
IPC: A61P9/12
Filed: 2002-10-22
Abstract: Disclosed are pyrimidine derivatives of formula (I) wherein: R1 and R2 are H; R3 is H, amino, halogen, cyano, alkyl, alkenyl, alkynyl, aromatic hydrocarbon cyclic group, aromatic heterocyclic group, N, O or S; R4 is a group of formula (IV) wherein R8 is as defined; and R5 represents an aromatic hydrocarbon cyclic group. Also disclosed is the use of the above compounds as adenosine A2A and A2B receptor antagonists useful in the treatment of Parkinson's disease, depression, constipation, diabetes, glucose intolerance, Alzheimer's disease, inflammatory bowel disease and Crohn's disease amongst other uses.
Patent NZ-541554-A (NZ)
Title: Method for mounting rotor blades and rotor blade for a wind turbine
Inventor: WOBBEN ALOYS
IPC: F03D1/06
Filed: 2004-01-20
Abstract: Disclosed is a method for mounting rotor blades on a rotor hub which is connected to a nacelle of a wind turbine. The method includes the following steps: rotation of the rotor hub into a predefined first position; mounting of a rotor blade (21); rotation of the rotor hub into a predefined second position with the aid of the mounted rotor blade (21) and mounting of a second rotor blade (22). The rotation of the rotor hub into the second position is performed in the direction of the gravitational force acting on the first rotor blade (21) which has already been mounted.
Patent NZ-544655-A (NZ)
Title: Apparatus and method for bioelectrics stimulation, healing acceleration, pain relief, or pathogen devitalization
Inventor: KRONBERG JAMES W
Filed: 2004-06-24
Abstract: An apparatus comprises an electrical signal generator configured to generate an electrical signal to be delivered by coupling means is disclosed. The electrical signal has at least four relatively longer primary timing intervals T1, T2, T3, T4 and others if present; at least two relatively shorter secondary timing intervals t1, t2 and so forth; a plurality of substantially constant voltage or current levels L1, L2 and so forth; one of the voltage or current levels during each of the secondary intervals within a the primary interval which is so divided, or during the whole of the primary interval if it is not so divided: the levels, selected in succession throughout the course of the primary cycle; and one or more of the primary intervals, the intervals being not so divided, as one or more equalizing pulses for the establishment of substantial charge balance throughout the course of anyone repetition of the primary cycle. Each of the primary timing intervals having a respective duration of between approximately 50 microseconds and approximately 30 seconds. The primary time intervals form, in succession, a repeating primary cycle. The primary cycle has a duration of between 200 msee and 120 seconds. Each of the shorter secondary timing intervals have a respective duration of between 2.55 microseconds and 50 milliseconds, into which at least one of the primary timing intervals is divided and which form, in succession, a repeating secondary cycle throughout its length. The secondary cycle has a respective duration of 5 microseconds to 50 milliseconds; while at least one other of the primary timing intervals is not so divided. The electrical signal generator comprises: a first timing interval generator configurable to generate the plurality of primary timing intervals T1, T2 and so forth, thereby forming the repeating primary cycle; and a second timing interval generator configurable to generate the plurality of secondary timing intervals t1, t2 and so forth, thereby forming the repeating secondary cycle during the at least one primary interval which is so divided.
Patent NZ-546442-A (NZ)
Title: Method for manufacturing a foam core having channel cuts
Inventor: DEFRANKS MICHAEL S
IPC: B29C/
Filed: 2004-10-13
Abstract: A block of foam 60 is convoluted between first and second matching rotors 62, 64 to form a tongue 70 extending along the block which is removed by the knife 66 to form a channel 76 within the block, and as the block moves between the incrementally rotating rotors a series of parallel channels 76 is formed in the foam. The first and second rotors have a plurality of matching projections separated by matching voids, the projections of the one rotor opposing the matching voids of the other rotor as the rotors rotate. The first rotor also includes a head section 72 (and possibly a tail section 74) which extends beyond a head end of the second rotor and has a substantially smooth surface so that the channels are not formed in the foam passing adjacent the head section.
Patent NZ-549627-A (NZ)
Title: Wall cladding
Inventor: WINSTANLEY GARETH
Filed: 2006-09-04
Abstract: A support member for supporting at least a pair of vertically adjacent wall cladding tiles. The support member includes: a body formed as an elongate channel which can be fixed to a wall being clad so that the channel extends vertically with respect to the wall in an installed condition; and at least two vertically spaced groups of supports. Each group of supports includes at least an upper support and a lower support which are vertically spaced in the installed condition of the support members, whereby the upper support is arranged to support a lower end of a first cladding tile and the lower support is arranged to support an upper end of a second cladding tile which is vertically adjacent and below the first cladding tile.
Patent NZ-549731-A (NZ)
Title: Methods and compositions for treatment of autoimmune diseases
Inventor: WUCHERPFENNIG KAI W
IPC: A61K38/02
Filed: 2005-03-01
Abstract: Disclosed is a copolymer composition comprising semi-random sequence copolymers having a general formula [XXXa1XXXXXXXXa2XX]n, wherein n is 2-8, X is any amino acid residue, and Xa1 and Xa2 are at least two fixed anchor residues which are separated by 7 amino acid residues, wherein: (1) the anchor residue is selected from aspartic acid residue (D) and glutamic acid residue (E); (2) the remainder of the copolymer has a random sequence comprising at least two amino acid residues, one amino acid selected from each amino acid residue group (a) alanine (A) or glycine (G); and (b) leucine (L), isoleucine (I), valine (V), methionine (M), threonine (T), serine (8), and cysteine (C); optionally further comprising proline (P) ; and wherein said copolymers bind to one or more HLA-DQ molecules. The compositions disclosed are useful in the treatment of autoimmune disease, unwanted immune responses and allergies. Also disclosed are methods of identifying the copolymers of the invention.
Patent NZ-552335-A (NZ)
Title: Combinations comprising a selective COX-2 inhibitor and a microtubule interfering agent
Inventor: CHEN YING-NAN PAN
IPC: A61K31/502
Filed: 2002-10-24
Abstract: Disclosed is a combination which comprises (a) a selective cyclooxygenase-2 inhibitor of the formula (I), wherein the substituents are as defined in the specification, and (b) a microtubule interfering agent, in which the active ingredients (a) and (b) are present in each case in free form or in the form of a pharmaceutically acceptable salt and optionally at least one pharmaceutically acceptable carrier; for simultaneous, separate or sequential use with the proviso that the microtubule interfering agent is not epothilone.
Patent NZ-554406-A (NZ)
Title: A rotisserie spit comprising a food cage
Inventor: THOMPSON RHETT LINTON
Filed: 2005-11-16
Abstract: An attachment for a spit rod of a rotisserie spit for use in cooking foods is disclosed. The attachment comprises a cylindrical cage 200 which is mountable to the spit. The cage can be loaded with products to be cooked via an access opening 210 at one end of the cylinder. The access opening can be closed allowing the products to be cooked with a tumbling action upon rotation of the spit.
Patent NZ-561946-A (NZ)
Title: Methods and compositions for the repair and/or regeneration of damaged myocardium
Inventor: ANVERSA PIERO
IPC: A61K35/12
Filed: 2003-03-12
Abstract: Provided is the use of at least one cytokine capable of mobilizing stem cells in the manufacture of a medicament for damaged myocardium, formulated for administration by injection near or within myocardium. The medicament may be given in multiple doses and in different cytokine concentrations in different doses.
Patent NZ-564202-A (NZ)
Title: Pyrrole derivatives as positive allosteric modulators of metabotropic glutamate receptors
Inventor: LINGARD IAIN
IPC: A61K31/415
Filed: 2006-05-17
Abstract: Disclosed herein are compounds of formula (I-b), wherein the substituents are as defined within the specification, as positive allosteric modulators of metabotropic receptors - subtype 5 ('mGluR5') which are useful for the treatment or prevention of central nervous system disorders such as for example, cognitive decline, both positive and negative symptoms in schizophrenia as well as other central or peripheral nervous system disorders in which the mGluR5 subtype of glutamate metabotropic receptor is involved. The invention is also directed to pharmaceutical compounds and compositions in the prevention or treatment of such diseases in which mGluR5 is involved.
Patent NZ-565770-A (NZ)
Title: Hubcap for heavy-duty vehicles
Inventor: WHITE JAY D
IPC: B60B7/00
Filed: 2006-07-27
Abstract: Disclosed is a hubcap for a wheel end assembly of a heavy-duty vehicle. The wheel end assembly having a wheel hub formed with a cavity for containing lubricant and an outboard end. The hubcap includes a cylindrical sidewall extending parallel to an axial centreline of the wheel end assembly when the hubcap is mounted on the wheel hub. The hubcap includes an outboard wall extending generally perpendicular to the sidewall. The outboard wall is formed with an opening. A cylindrical structure extends inboardly from an inboard surface of the outboard wall. The cylindrical structure includes a wall with an inner cylindrical surface and an outer cylindrical surface. The cylindrical structure is formed with an opening that is generally aligned with the outboard wall opening and which terminates at a generally closed inboard end of the cylindrical structure. The hubcap further includes a lip extending inboardly from the sidewall, a shoulder extending radially outwardly from the sidewall and seal means disposed between the lip and the wheel hub. The lip and the shoulder cooperate to positively engage the wheel hub outboard end and the seal means seals the engagement. The lip and the shoulder further cooperate with the wheel hub outboard end to align the outboard wall opening and the cylindrical structure opening with a central axis of an axle spindle end.
Patent NZ-567574-A (NZ)
Title: 1,2,3-triazolopyridine derivatives as inhibitors of lipases and phospholipases
Inventor: PETRY STEFAN
IPC: A61K31/4192
Filed: 2006-10-12
Abstract: Disclosed are 1,2,3-triazolopyridine derivatives of formula I, wherein X is identically or differently =C(-R)- or =N-, where at least one and at most two X is =N-; W is -(C=O)-, -(S=O)-, -(SO2)-; wherein the other substituents are as disclosed herein. Also disclosed is the use of the compounds as defined above for the production of a medicament for the treatment and/or prevention of disorders of fatty acid metabolism and glucose utilization disorders, disorders where insulin resistance is involved, conditions associated with the metabolic syndrome, conditions associated with a reduced HDL level (disorders such as diabetes, mellitus and the sequelae associated therewith, dyslipidemias and their sequelae and atherosclerotic disorders). Further disclosed are processes for the preparation of the above compounds.
Patent NZ-568163-A (NZ)
Title: Methods of identifying individual nucleotides using pores
Inventor: BAYLEY HAGAN
IPC: C12Q1/68
Filed: 2006-11-15
Abstract: Disclosed is a method of identifying an individual monophosphate nucleotide, comprising: a) contacting the monophosphate nucleotide with a transmembrane protein pore having a current passing through it, so that the monophosphate nucleotide interacts with the pore; and b) measuring the current passing through the pore during the interaction and thereby determining the identity of the monophosphate nucleotide, wherein the pore comprises a molecular adaptor that facilitates the interaction between the monophosphate nucleotide and the pore.
Patent NZ-575889-A (NZ)
Title: Hcv nucleoside inhibitor
Inventor: JOHANSSON NILS-GUNNAR
IPC: A61P31/12
Filed: 2007-10-04
Abstract: Disclosed is a compound of formula (I), wherein the substituents are as defined in the specification, and processes for their preparation. The compounds are inhibitors of RNA-dependent RNA viral polymerase and useful as inhibitors of hepatitis C virus (HCV) NS5B polymerase, as inhibitors of HCV replication, and for the treatment of hepatitis C infection.
Patent NZ-576563-A (NZ)
Title: Alphavirus and alphavirus replicon particle formulations and methods
Inventor: DEPAZ ROBERTO
IPC: A61K9/19
Filed: 2007-11-02
Abstract: Provided is a dried composition with rehydration and storage stability comprising (1) alphaviruses or alphavirus replicon particles, (2) a salt, (3) a surfactant, and (4) a hydrogen-bonding sugar, sugar alcohol or other polyol, wherein the hydrogen-bonding sugar, sugar alcohol or other polyol is selected from trehalose, sucrose, raffinose, maltodextrin, fructose, glycerol, sorbitol, inositol and mannose, and (5) a plasticizer. The alphavirus can be Venezuelan Equine Encephalitis Virus (VEE).
Patent NZ-584043-A (NZ)
Title: Package comprising a protection pouch for a drug dispensing inhaler device
Inventor: BERRY SIMON
IPC: B65D5/48
Filed: 2008-10-01
Abstract: A package for a drug-dispensing device is disclosed, which comprises: a protection pouch arranged to enclose the drug-dispensing device (preferably comprising an inhaler), the protection pouch comprising a pouch material with an upper sealing edge and a lower sealing edge, the upper and lower sealing edges defining a pouch there-between, the pouch arranged to support the drug-dispensing device in a general vertical direction, wherein the package comprises two support members arranged to support the protection pouch, wherein: the protection pouch comprises two vertical side seals; one of the support members is attached to or integrally formed with each one of the vertical side seals; and the support members are configured to be rigid yet flexible enough to support the protection pouch when arranged in a box, wherein the support members are provided with a stiffening texture preferably by a heat welding process.
Patent NZ-586344-A (NZ)
Title: Downlight with a lamp shade body having a heat-radiating device and an expandable element to protect the lamp shade body
Inventor: WU LIANGJU
IPC: F21V29/00
Filed: 2008-12-10
Abstract: Disclosed is a recessed-type lamp. The lamp is comprised of a lamp shade body (1) and a lamp body (2) installed in the lamp shade body (1). A radiant heat device (3) is also provided connected to the lamp shade body. The lamp further includes a flame-proof expansion piece (4) provided to prevent the radiant heat device (3) from overheating and causing damage due to flames within the lamp shade body (1).
Patent NZ-588677-A (NZ)
Title: Pharmaceutical depot comprising n-{ 5-[(cyclopropylamino)carbonyl]-2-methylphenyl} -3-fluoro-4-(pyridin-2-ylmethoxy)benzamide
Inventor: BATEMAN NICOLA FRANCES
IPC: A61K9/16
Filed: 2009-04-09
Abstract: Disclosed herein is a pharmaceutical depot formulated for administration by intra-articular injection to a joint of a subject suffering from osteoarthritis, comprising microparticles or nanoparticles comprised of N-{ 5-[(cyclopropylamino)carbonyl]-2-methylphenyl} -3-fluoro-4-(pyridine-2-ylmethoxy)benzamide, or a pharmaceutically acceptable salt thereof, and a biodegradable lactic acid-glycolic acid copolymer.
Patent NZ-591499-A (NZ)
Title: Co-production of synthesis gas and power
Inventor: GREEFF ISABELLA LODEWINA
IPC: F01K23/10
Filed: 2009-08-18
Abstract: A process for co-producing synthesis gas and power, the process including in a synthesis gas generation stage, producing a hot synthesis gas at a temperature of at least 650 degrees C and comprising at least CO and hydrogen from a carbonaceous feedstock; and in a nuclear power generation stage, heating a working fluid with heat generated by a nuclear reaction to produce a heated working fluid and generating power by expanding the heated working fluid using one or more turbines, with additional heating of the heated working fluid to a temperature above 600 degrees C by indirect transfer of heat from the hot synthesis gas to the heated working fluid.
Patent NZ-592241-A (NZ)
Title: Ykl-40 as a marker for gastrointestinal cancers
Inventor: JOHANSEN JULIA SIDENIUS
IPC: G01N33/574
Filed: 2009-09-14
Abstract: The present invention relates to gastrointestinal cancers and methods for selecting a treatment for said gastrointestinal cancer in a subject. The present invention further relates to a methods of diagnosing the presence of and/or classifying the severity of a gastrointestinal cancer; together with methods for determining the effect of a therapy administered and/or the prognosis for a subject suffering from a gastrointestinal cancer, before, during or after administering the treatment. For all the methods applies that a determined level of YKL-40 above one or more reference levels indicates the treatment, the severity of the disease, the effect of the treatment and/or the prognosis of the subject. The reference level is typically a level obtained from healthy individuals or a level previously obtained from the same subject. The subject may suffer from any one or more gastrointestinal cancers, such as upper gastrointestinal cancers, and metastatic colorectal cancer. The present invention further relates to a kit and a device that may be used in the method of the present invention.
Patent NZ-593299-A (NZ)
Title: Nozzle for a caulking gun comprising first tube threaded externally and second tube threaded internally for connection
Inventor: BUCHANAN BRIAN DAVID
IPC: B65D83/28
Filed: 2011-06-07
Abstract: A nozzle (10) for a caulking gun cartridge is disclosed. The nozzle (10) comprises a first inflexible tube (12) comprising a first portion (18) and the second portion (20). The first portion (18) tapers inwardly from a location adjacent a first end to a second end. The second portion (20) extends from the second end of the first portion (18) at an angle to the first portion (18). The second portion (20) includes an external thread. The nozzle (10) further comprises a second tube (14) that includes an internal thread at its first end. The first end of the second tube (14) is threaded onto the second portion (20) of the first tube (12) to provide an angled nozzle (10).
Patent NZ-594184-A (NZ)
Title: Skin treatment
Inventor: THOMAS DAVID
IPC: A61Q19/08
Filed: 2010-02-12
Abstract: 594184 Disclosed is the use of an isolated or purified ingenol compound or a pharmaceutically acceptable salt thereof in the manufacture of a medicament for the treatment of chronologically-aged and/or photo-aged skin or for inducing endogenous synthesis of hyaluronan in a subject, wherein said medicament is for topical administration to lines, wrinkles, furrows or sunspots on said skin. Examples of the ingenol compound are: ingenol-3-angelate, 20-O-acetyl-ingenol-3-angelate and 20-deoxyingenol-3-angelate. Also disclosed is the cosmetic method of chronologically-aged and/or photo-aged skin in a subject comprising topically administering a composition comprising an isolated or purified ingenol compound or a pharmaceutically acceptable salt thereof to lines, wrinkles, furrows or sunspots on the skin of said subject.